IFNA1 and hepatocellular carcinoma: This systematic review supports the beneficial effects of IFN-based treatment for decreasing HCC incidence in HCV-related cirrhotic patients, and HCC recurrence rate in HCV-related HCC patients after curative HCC therapy.